CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical ...
China orthosis and prosthetics market is estimated to be valued at US$ 1,740.1 Mn in 2023 and is expected to exhibit a CAGR of 5.3% by forecast period 2023-2030 BURLINGAME, CA, UNITED STATES, February ...
Ottobock aims for over 6 billion -euro valuation, source says Family may sell 25%-30% of shares, with phased divestment possible Frankfurt and Zurich expected to lead European IPO revival BERLIN, Sept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback